- Home
- /Hemoglobin disorders newborn screening comment-discussion
Hemoglobin disorders newborn screening comment-discussion
Screens newborn blood for genetic hemoglobin disorders including sickle cell disease.
Why This Biomarker Matters
Early detection of hemoglobin disorders enables immediate treatment and preventive care. Allows families to avoid serious complications and plan appropriate medical management from birth.
Overview
This test involves newborn screening for hemoglobin disorders—genetic conditions affecting red blood cell function, such as sickle cell disease and thalassemia. Blood is collected from a newborn heel prick on a filter card. Early detection allows for immediate treatment and management, preventing serious complications like pain crises, organ damage, and death. Most U.S. states include hemoglobin screening in routine newborn panels. Results include interpretive comments guiding follow-up testing and pediatric care.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
57703-1PrimaryAvailable Lab Tests
Order tests that measure this biomarker